Skip to content

Jean-Michel Aubry

2 papers in the library · publishing 2017-2018

Papers

Sort Most recent Most cited

Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study.

Journal of Clinical Psychopharmacology December 2018 Sonia Vidal, Marianne Gex-Fabry, Victor Bancila et al.

Ketamine has been documented for its rapid antidepressant effects. However, optimal dose and delivery route have not yet been thoroughly investigated. The objectives of this study were to document the safety and test the antidepressant and antisuicidal effects of a single rapid 1-minute injection of ketamine 0.5 mg/kg in treatment-resistant depression (TRD). Ten patients with TRD were included...

Self-Reported Long-Term Benefits of Mindfulness-Based Cognitive Therapy in Patients with Bipolar Disorder.

The Journal of Alternative and Complementary Medicine July 2017 Béatrice Weber, Loretta Sala, Marianne Gex-Fabry et al.

This study focused on patients with bipolar disorder (BD), several years after their participation in mindfulness-based cognitive therapy (MBCT). It aimed at documenting sustained mindfulness practice, perceived long-term benefit from the program, and changes regarded as direct consequences of the intervention. This cross-sectional survey took place at least 2 years after MBCT for 70.4% of...

DOI: 10.1089/acm.2016.0427 (opens in new tab) Full text (opens in new tab) Bipolar disorder Long-term benefit Mindfulness practice Mindfulness-based cognitive therapy +2